Trial · NCT00752986
Adverse events189
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 189
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | RIGHT HYPOCHONDRIUM PAIN | Gastrointestinal disorders | Vandetanib at the Dose of 100 mg | 0 | 16 | 0 |
| other | RIGHT HYPOCHONDRIUM PAIN | Gastrointestinal disorders | Vandetanib at the Dose of 300 mg | 0 | 12 | 0 |
| other | RIGHT HYPOCHONDRIUM PAIN | Gastrointestinal disorders | Placebo to Match Vandetanib 100 mg and 300 mg | 1 | 11 | 1 |
| other | AST ELEVATION | Blood and lymphatic system disorders | Vandetanib at the Dose of 100 mg | 0 | 16 | 0 |
| other | AST ELEVATION | Blood and lymphatic system disorders | Vandetanib at the Dose of 300 mg | 0 | 12 | 0 |
| other | AST ELEVATION | Blood and lymphatic system disorders | Placebo to Match Vandetanib 100 mg and 300 mg | 1 | 11 | 1 |
| other | RECTAL BLEEDING | General disorders | Vandetanib at the Dose of 100 mg | 0 | 16 | 0 |
| other | RECTAL BLEEDING | General disorders | Vandetanib at the Dose of 300 mg | 0 | 12 | 0 |
| other | RECTAL BLEEDING | General disorders | Placebo to Match Vandetanib 100 mg and 300 mg | 1 | 11 | 1 |
| other | HEMORRHOIDS | General disorders | Vandetanib at the Dose of 100 mg | 0 | 16 | 0 |
| other | HEMORRHOIDS | General disorders | Vandetanib at the Dose of 300 mg | 0 | 12 | 0 |
| other | HEMORRHOIDS | General disorders | Placebo to Match Vandetanib 100 mg and 300 mg | 1 | 11 | 1 |
| other | ANAEMIA | Blood and lymphatic system disorders | Vandetanib at the Dose of 100 mg | 1 | 16 | 3 |
| other | ANAEMIA | Blood and lymphatic system disorders | Vandetanib at the Dose of 300 mg | 0 | 12 | 0 |
| other | ANAEMIA | Blood and lymphatic system disorders | Placebo to Match Vandetanib 100 mg and 300 mg | 1 | 11 | 1 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Vandetanib at the Dose of 100 mg | 0 | 16 | 0 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Vandetanib at the Dose of 300 mg | 0 | 12 | 0 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Placebo to Match Vandetanib 100 mg and 300 mg | 1 | 11 | 1 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Vandetanib at the Dose of 100 mg | 0 | 16 | 0 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Vandetanib at the Dose of 300 mg | 0 | 12 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00752986/events